<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Extracellular and intracellular signaling</title>
  </titleInfo>
  <name type="personal">
    <namePart>Adams, J. D. (James D.)</namePart>
  </name>
  <name type="personal">
    <namePart>Parker, Keith K. (Keith Krom)</namePart>
  </name>
  <name type="corporate">
    <namePart>Royal Society of Chemistry (Great Britain)</namePart>
  </name>
  <typeOfResource/>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">enk</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Cambridge, UK</placeTerm>
    </place>
    <publisher>RSC Pub.</publisher>
    <dateIssued>c2011</dateIssued>
    <dateIssued encoding="marc">2011</dateIssued>
    <issuance/>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <extent>xiii, 303 p. : ill. (some col.) ; 24 cm.</extent>
  </physicalDescription>
  <abstract>"Intracellular cell signaling is a well understood process. However, extracellular signals such as hormones, adipokines, cytokines and neurotransmitters are vital to the process and have been largely ignored in other works on signaling. They are causative agents in hypertension, diabetes, heart disease, arthritis and other diseases. Aimed at medical professionals and pharmaceutical specialists, this book integrates for the first time extracellular and intracellular signaling processes and offers a fresh perspective on new targets for drug development. With contributions from leading international authorities, it is the result of close cooperation between the authors of the various chapters. Readers are introduced to a new approach to disease causation by adipokines and toxic lipids. Heart disease, migraines, stroke, Alzheimer's disease, diabetes, cancer, and arthritis are approached from the perspective of toxic lifestyle and accumulation of toxic proteins and lipids. Evidence is presented that by alterations in toxic lifestyles you can reduce the incidence of such diseases. New therapeutic targets involving adipokines, ceramide and endocannabinoids are also discussed."--Back cover.</abstract>
  <note type="statement of responsibility">edited by James D. Adams, Jr., Keith K. Parker</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Cellular signal transduction</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cell interaction</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <classification authority="lcc">QP517.C45</classification>
  <identifier type="isbn">9781849731607 (hbk.)</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">UIAM</recordContentSource>
    <recordCreationDate encoding="marc">121119</recordCreationDate>
    <recordChangeDate encoding="iso8601">20250226062939.0</recordChangeDate>
    <recordIdentifier source=" ">753840693</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
